血清CA15-3、CA50、CA19-9和IL-8检测对女性乳腺癌的诊断价值  

作　　者：高永旺[1] 蒋炳辰[1] 

机构地区：[1]广西北海市人民医院核医学科,北海536000

出　　处：《北方药学》2014年第1期66-67,共2页Journal of North Pharmacy

摘　　要：目的:探讨血清CA15-3、CA50、CA19-9和IL-8检测对乳腺癌患者诊断的临床意义。方法:应用放射免疫法和化学发光法对34例乳腺癌患者(均为女性)进行血清的CA15-3、CA50、CA19-9和IL-8检测,并与34名正常人(均为女性)进行相关对比分析。结果:乳腺癌患者的CA15-3、CA50和IL-8含量水平明显高于对照组(P<0.05),而CA19-9与正常人对照组无明显差异(P>0.05)。结论:血清CA15-3、CA50和IL-8的检测对乳腺癌的发病、预防、诊断和治疗均有重要的临床价值。Objective：To investigate the clinical signficance of differences on serum CA15-3,CA50,CA19-9, IL-8 levels detection in patients with breast cancer. Methods ： Serum CA15-3, CA50, CA19-9,IL-8 concentration from 34 patients （female） with breast cancer and 34 healthy normal controls （female） were determined by RIA and CLIA. Results：The serum CA15-3, CA50, IL-8 levels in patients with breast cancer were significant higher than those in controls. But the serum CA19-9 levels were no significant difference from those in controls.Conclusion： Detection of serum CA15-3,CA50,IL-8 levels might be of prognostic importance in patients with breast cancer.

关 键 词：导L腺癌CAl5-3 CA50 CA19-9 IL-8 

分 类 号：R737.9[医药卫生—肿瘤]